An International Evaluation of Drug-Drug Interaction Alerts That Should be Non-Interruptive in U.K. and U.S. Settings.

(Persons using assistive technology may not be able to fully access information in this report. For assistance, please contact ahrqsection508@ahrq.hhs.gov)
Principal Investigator
Document Type
Population
Medical Condition